These core targets were mostly concentrated on several KEGG pathways, like IL-17, AGE-RAGE, TNF, HIF-1, PI3K-AKT, NOD-like receptor, T/B cell receptor, and virus infection-related pathways, indicating their important parts in the treatment of pulmonary fibrosis. The gene discussed is AKT1; the disease is viral infectious disease.